Publications (190) Publications in which a researcher has participated

filter_list

2025

  1. 18F-Labeled Fluorodeoxyglucose-Positron Emission Tomography/Computed Tomography in Staging and Restaging Patients With Breast Cancer

    Journal of Clinical Oncology

  2. Awareness of genomic testing among patients with breast cancer in Europe

    Breast, Vol. 81

  3. Clinico-pathological features predicting indication to mastectomy in breast cancer patients achieving complete response after neoadjuvant therapy: A retrospective analysis of the EUSOMA database

    European Journal of Surgical Oncology, Vol. 51, Núm. 6

  4. Correction to: Uncovering functional lncRNAs by scRNA-seq with ELATUS (Nature Communications, (2024), 15, 1, (9709), 10.1038/s41467-024-54005-7)

    Nature Communications

  5. Determinants of Adherence to World Cancer Research Fund/American Institute for Cancer Research Recommendations in Women with Breast Cancer

    Cancers, Vol. 17, Núm. 4

  6. Multidisciplinary team meeting (MDT) in cancer care: All that glitters is not gold

    European Journal of Surgical Oncology

  7. New Approach in the Interpretation of Complex Triple-negative Breast Cancer Immunohistochemistry Specimens Processed With VENTANA PD-L1 (SP142) Assay

    Applied immunohistochemistry & molecular morphology : AIMM, Vol. 33, Núm. 1, pp. 15-21

  8. Radar reflectors for marking of target lymph nodes in initially node-positive patients receiving neoadjuvant chemotherapy for breast cancer—a subgroup analysis of the prospective AXSANA (EUBREAST-03) trial

    Breast Cancer Research and Treatment, Vol. 211, Núm. 1, pp. 203-211

  9. Reply letter to: Specialised oncology training for effective multidisciplinary cancer care

    European Journal of Surgical Oncology

  10. Ultrasound imaging of the normal axilla: Anatomical characteristics of lymph nodes and age-related variations

    Radiologia

2024

  1. A multidisciplinary team and patient perspective on omission of surgery after neoadjuvant systemic therapy for early breast cancer: A European Society of Surgical Oncology (ESSO) Research Academy survey

    European Journal of Surgical Oncology, Vol. 50, Núm. 10

  2. Benefit of systemic therapy in MINDACT patients with small, ER-positive, HER2-negative breast cancers

    npj Breast Cancer, Vol. 10, Núm. 1

  3. Corrigendum to “European guidelines for the diagnosis, treatment and follow-up of breast lesions with uncertain malignant potential (B3 lesions) developed jointly by EUSOMA, EUSOBI, ESP (BWG) and ESSO” [Eur J Surg Oncol 50 (1) (January 2024) 107292] (European Journal of Surgical Oncology (2024) 50(1), (S0748798323009307), (10.1016/j.ejso.2023.107292))

    European Journal of Surgical Oncology

  4. Current Management and Future Perspectives in Metastatic HER2-Positive Breast Cancer

    Seminars in Oncology Nursing, Vol. 40, Núm. 1

  5. Dendritic Cells in Cancer Immunology and Immunotherapy

    Cancers, Vol. 16, Núm. 5

  6. ESR Bridges: image-guided breast cancer treatment de-escalation—a multidisciplinary view

    European Radiology

  7. EUSOMA quality indicators for non-metastatic breast cancer: An update

    European Journal of Cancer, Vol. 198

  8. European guidelines for the diagnosis, treatment and follow-up of breast lesions with uncertain malignant potential (B3 lesions) developed jointly by EUSOMA, EUSOBI, ESP (BWG) and ESSO

    European Journal of Surgical Oncology, Vol. 50, Núm. 1

  9. Joint EANM-SNMMI guideline on the role of 2-[18F]FDG PET/CT in no special type breast cancer: (endorsed by the ACR, ESSO, ESTRO, EUSOBI/ESR, and EUSOMA)

    European Journal of Nuclear Medicine and Molecular Imaging, Vol. 51, Núm. 9, pp. 2706-2732

  10. Joint EANM-SNMMI guidelines on the role of 2-[18F]FDG PET/CT in no special type breast cancer: differences and agreements with European and American guidelines

    European Journal of Nuclear Medicine and Molecular Imaging